JP2005533795A - 経皮エアゾール組成物 - Google Patents

経皮エアゾール組成物 Download PDF

Info

Publication number
JP2005533795A
JP2005533795A JP2004514437A JP2004514437A JP2005533795A JP 2005533795 A JP2005533795 A JP 2005533795A JP 2004514437 A JP2004514437 A JP 2004514437A JP 2004514437 A JP2004514437 A JP 2004514437A JP 2005533795 A JP2005533795 A JP 2005533795A
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
composition according
pressure gas
drugs
skin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2004514437A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005533795A5 (https=
Inventor
ゴンダ，イゴール
モルガン，ティモシー，マティアス
ウィルキンス，ニナ，フランセス
Original Assignee
アクラックス ディーディーエス ピーティーワイ エルティーディー
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by アクラックス ディーディーエス ピーティーワイ エルティーディー filed Critical アクラックス ディーディーエス ピーティーワイ エルティーディー
Publication of JP2005533795A publication Critical patent/JP2005533795A/ja
Publication of JP2005533795A5 publication Critical patent/JP2005533795A5/ja
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7015—Drug-containing film-forming compositions, e.g. spray-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Psychology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP2004514437A 2002-06-25 2003-06-24 経皮エアゾール組成物 Withdrawn JP2005533795A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPS3171A AUPS317102A0 (en) 2002-06-25 2002-06-25 Transdermal aerosol compositions
PCT/AU2003/000784 WO2004000275A1 (en) 2002-06-25 2003-06-24 Transdermal aerosol compositions

Publications (2)

Publication Number Publication Date
JP2005533795A true JP2005533795A (ja) 2005-11-10
JP2005533795A5 JP2005533795A5 (https=) 2006-06-22

Family

ID=3836730

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004514437A Withdrawn JP2005533795A (ja) 2002-06-25 2003-06-24 経皮エアゾール組成物

Country Status (9)

Country Link
EP (1) EP1534241A1 (https=)
JP (1) JP2005533795A (https=)
KR (1) KR20050071373A (https=)
AU (1) AUPS317102A0 (https=)
BR (1) BR0312004A (https=)
CA (1) CA2490325A1 (https=)
EA (1) EA007351B1 (https=)
NZ (1) NZ537435A (https=)
WO (1) WO2004000275A1 (https=)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2014505727A (ja) * 2011-02-15 2014-03-06 イーライ リリー アンド カンパニー フェンタニルの経皮溶液を使用してウマ科動物において疼痛を抑制するための方法
JP2014505726A (ja) * 2011-02-15 2014-03-06 イーライ リリー アンド カンパニー フェンタニルの経皮溶液を使用してイヌにおける疼痛を抑制するための方法

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20050045946A (ko) * 2002-06-25 2005-05-17 애크럭스 디디에스 피티와이 리미티드 비정질 약학적 조성물을 이용한 경피전달속도의 제어
JP2007511544A (ja) * 2003-11-19 2007-05-10 アクルックス・ディ・ディ・エス・プロプライエタリー・リミテッド アミロイド症の予防若しくは治療のための組成物および方法
US20060263421A1 (en) 2005-05-18 2006-11-23 Abeille Pharmaceuticals Inc Transdermal Method and Patch for Nausea
ES2494853T3 (es) * 2007-11-02 2014-09-16 Acrux Dds Pty Ltd Sistema de administración transdérmica
US12459965B2 (en) 2017-10-09 2025-11-04 Compass Pathfinder Limited Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use
GB2571696B (en) 2017-10-09 2020-05-27 Compass Pathways Ltd Large scale method for the preparation of Psilocybin and formulations of Psilocybin so produced
KR20220009954A (ko) 2019-04-17 2022-01-25 컴퍼스 패쓰파인더 리미티드 신경인지 장애, 만성 통증을 치료하고 염증을 감소시키는 방법

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5082866A (en) * 1988-06-01 1992-01-21 Odontex, Inc. Biodegradable absorption enhancers
AUPN814496A0 (en) * 1996-02-19 1996-03-14 Monash University Dermal penetration enhancer
US6004969A (en) * 1996-04-15 1999-12-21 National Science Council Transdermal delivery of buprenorphine preparations
NZ513208A (en) * 1999-02-05 2003-05-30 Cipla Ltd Topical sprays comprising a film forming composition
IN191090B (https=) * 2000-08-29 2003-09-20 Ranbanx Lab Ltd

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2014505727A (ja) * 2011-02-15 2014-03-06 イーライ リリー アンド カンパニー フェンタニルの経皮溶液を使用してウマ科動物において疼痛を抑制するための方法
JP2014505726A (ja) * 2011-02-15 2014-03-06 イーライ リリー アンド カンパニー フェンタニルの経皮溶液を使用してイヌにおける疼痛を抑制するための方法

Also Published As

Publication number Publication date
KR20050071373A (ko) 2005-07-07
NZ537435A (en) 2006-02-24
CA2490325A1 (en) 2003-12-31
AUPS317102A0 (en) 2002-07-18
WO2004000275A1 (en) 2003-12-31
EP1534241A1 (en) 2005-06-01
EA200500082A1 (ru) 2005-06-30
EA007351B1 (ru) 2006-10-27
BR0312004A (pt) 2005-03-29

Similar Documents

Publication Publication Date Title
US20050186141A1 (en) Transdermal aerosol compositions
EP1674068B1 (en) Dermal penetration enhancers and drug delivery systems involving same
US6923983B2 (en) Transdermal delivery of hormones
CA2359640C (en) Topical sprays
JP4871728B2 (ja) 起泡性医薬組成物および障害の治療方法
US20040013620A1 (en) Transdermal delivery of antiparkinson agents
US20070280972A1 (en) Adhesive solid gel-forming formulations for dermal drug delivery
KR20100055542A (ko) 비정질 약학적 조성물을 이용한 경피전달속도의 제어
JP2000143540A (ja) 非ステロイド系消炎鎮痛薬含有外用剤
US20070275943A1 (en) Method and Composition for Treatment or Prophylaxis of Amyloidosis Disorders
WO2004006960A1 (ja) 経皮吸収製剤
JP2005533795A (ja) 経皮エアゾール組成物
ES2533854T3 (es) Composiciones farmacéuticas transdérmicas que comprenden danazol
IL137559A (en) A system for administering drugs through the skin
WO2008012071A2 (en) Pharmaceutical compositions of nicotine and methods of use thereof
JP2005533795A5 (https=)
AU2003238543B2 (en) Transdermal aerosol compositions
ES2297183T3 (es) Formulaciones de aerosol que contienen esteres de derivados del 3,17-dihidroxi estratrieno para administracion pulmonar.
JPH06184000A (ja) （−）−イソプレゴールからなる経皮吸収促進剤
HK1087355B (en) Dermal penetration enhancers and drug delivery systems involving same
JP2010248250A (ja) 準安定性医薬組成物
JPH08283161A (ja) 鎮痛用外用剤

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20060426

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20060426

A761 Written withdrawal of application

Free format text: JAPANESE INTERMEDIATE CODE: A761

Effective date: 20090814

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20090925